1.
Chen Z, Giotti B, Kaluzova M, et al. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. The Journal of clinical investigation. 2023;133(22). doi:10.1172/JCI163802.
1.
Yu D-M, Zhao J, Lee EE, et al. GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. The Journal of clinical investigation. 2023;133(21). doi:10.1172/JCI170706.
1.
Stewart H, Lu Y, O’Keefe S, et al. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity. iScience. 2023;26(11):108080. doi:10.1016/j.isci.2023.108080.
1.
Hacken ET, Gruber M, Hernández-Sánchez M, et al. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing. STAR protocols. 2023;4(4):102165. doi:10.1016/j.xpro.2023.102165.
1.
Wang Y, Wu T, Tsai M-C, et al. TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice. eLife. 2023;12. doi:10.7554/eLife.83451.
1.
Ugai T, Shimizu T, Kawamura H, et al. Inverse relationship between amount and tumor CD274 (PD-L1) expression in colorectal carcinoma. Clinical & translational immunology. 2023;12(8):e1453. doi:10.1002/cti2.1453.
1.
Chew K, Lee B, Ozonoff A, et al. A protocol for high-throughput screening for immunomodulatory compounds using human primary cells. STAR protocols. 2023;4(3):102405. doi:10.1016/j.xpro.2023.102405.